Nanoparticles and innate immunity: new perspectives on host defence

Seminars in Immunology

Volumn 34, Issue , 2017, Pages 33-51

  Boraschi, Diana ^a   Italiani, Paola ^a   Palomba, Roberto ^b   Decuzzi, Paolo ^b   Duschl, Albert ^c   Fadeel, Bengt ^d   Moghimi, S Moein ^e,f  

^a INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

^b ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^c UNIVERSITY OF SALZBURG   (Austria)

^d KAROLINSKA INSTITUTE   (Sweden)

^e DURHAM UNIVERSITY   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Complement; Engineered nanoparticles; Immunosafety; Inflammation; Innate immunity; Toxicity

Indexed keywords

INFLAMMASOME; LECTIN; LIPOPOLYSACCHARIDE; NANOPARTICLE;

ASTHMA; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYMATIC DEGRADATION; EXTRACELLULAR TRAP; GRANULOCYTE; HOST RESISTANCE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; INTERNALIZATION; MACROPHAGE; MONOCYTE; NANOENGINEERING; NONHUMAN; PHAGOCYTE; REVIEW; SURFACE PROPERTY; ANIMAL; CHEMISTRY; IMMUNOLOGY; METABOLISM; PARTICLE SIZE; VACCINATION;

ANIMALS; COMPLEMENT ACTIVATION; DENDRITIC CELLS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; LIPOPOLYSACCHARIDES; NANOPARTICLES; PARTICLE SIZE; VACCINATION;

EID: 85028379680     PISSN: 10445323     EISSN: 10963618     Source Type: Journal    
DOI: 10.1016/j.smim.2017.08.013     Document Type: Review

References (270)

1. Boraschi, D., Moghimi, S.M., Duschl, A., Interaction between the immune system and nanomaterials: safety and medical exploitation. Curr. Bionanotechnol. 2 (2016), 3–5.
2. Boraschi, D., Duschl, A., (eds.) Nanoparticles and the Immune System: Safety and Effects, 2014, Elsevier Academic Press, Amsterdam.
3. Shvedova, A.A., Kagan, V.E., Fadeel, B., Close encounters of the small kind: adverse effects of man-made materials interfacing with the nano-cosmos of biological systems. Ann. Rev. Pharmacol. Toxicol. 50 (2010), 63–88.
4. Boraschi, D., Fadeel, B., Duschl, A., Immune system. Fadeel, B., Pietroiusti, A., Shvedova, A., (eds.) Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health, second edition, 2017, Elsevier-Academic Press, Amsterdam, 313–337.
5. Zahr, A.S., Davis, C.A., Pishko, M.W., Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol). Langmuir 22 (2006), 8178–8185.
6. Dobrovolskaia, M.A., McNeil, S.E., Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2 (2007), 469–478.
7. Dobrovolskaia, M.A., Aggarwal, P., Hall, J.B., McNeil, S.E., Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 5 (2008), 487–495.
8. Aggarwal, P., Hall, J.B., McLeland, C.B., Dobrovolskaia, M.A., McNeil, S.E., Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Deliv. Rev. 61 (2009), 428–437.
9. Fang, C., Shi, B., Pei, Y.Y., Hong, M.H., Wu, J., Chen, H.Z., In vivo tumor targeting of tumor necrosis factor alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur. J. Pharm. Sci. 27 (2006), 27–36.
10. Casals, E., Pfaller, T., Duschl, A., Oostingh, G.J., Puntes, V., Time evolution of the nanoparticle protein corona. ACS Nano 4 (2010), 3623–3632.
11. Mahon, E., Salvati, A., Baldelli Bombelli, F., Lynch, I., Dawson, K.A., Designing the nanoparticle-biomolecule interface for targeting and therapeutic delivery. J. Controlled Release 161 (2012), 164–174.
12. Monopoli, M.P., Pitek, A.S., Lynch, I., Dawson, K.A., Formation and characterization of the nanoparticle protein corona. Methods Mol. Biol. 1025 (2013), 137–155.
13. Esmaeili, F., Ghahremani, M.H., Esmaeili, B., Khoshayand, M.R., Atyabi, F., Dinarvand, R., PLGA nanoparticles of different surface properties: preparation and evaluation of their body distribution. Int. J. Pharm. 349 (2008), 249–255.
14. Fleischer, C.C., Payne, C.K., Nanoparticle surface charge mediates the cellular receptors used by protein-nanoparticle complexes. J. Phys. Chem. B 116:2008 (2012), 8901–8907.
15. Moghimi, S.M., Muir, I.S., Illum, L., Davis, S.S., Kolb-Bachofen, V., Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta 1179 (1993), 157–165.
16. Boraschi, D., Italiani, P., Model validity in nanoimmunosafety: advantages and disadvantages of in vivo vs. in vitro models, and human vs. animal models. Duschl, A., Boraschi, D., (eds.) Interaction Between the Immune System and Nanomaterials. 2. Models and Exploitation Strategies, Current Bionanotechnol., 2, 2016, 71–76.
17. Oostingh, G.J., Casals, E., Italiani, P., Colognato, R., Stritzinger, R., Ponti, J., Pfaller, T., Kohl, Y., Ooms, D., Favilli, F., Leppens, H., Lucchesi, D., Rossi, F., Nelissen, I., Thielecke, H., Puntes, V.F., Duschl, A., Boraschi, D., Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects. Part. Fibre Toxicol., 8, 2011, 8.
18. Krug, H.F., Nanosafety research – are we on the right track? Some thoughts based on a comprehensive literature review. Angew. Chem. Int. Ed. 53 (2014), 12304–12319.
19. Li, Y., Boraschi, D., Endotoxin contamination: a key element in the interpretation of nanosafety studies. Nanomed. Future Med. 11 (2016), 269–287.
20. Li, Y., Fujita, M., Boraschi, D., Endotoxin contamination in nanomaterials leads to the misinterpretation of immunosafety results. Front. Immunol., 8, 2017, 472.
21. Li, Y., Italiani, P., Casals, E., Tran, N., Puntes, V.F., Boraschi, D., Optimising the use of commercial LAL assays for the analysis of endotoxin contamination in metal colloids and metal oxide nanoparticles. Nanotoxicology 9 (2015), 462–473.
22. Schwarz, H., Gornicec, J., Neuper, T., Parigiani, M.A., Wallner, M., Duschl, A., Horejs-Hoeck, J., Biological activity of masked endotoxin. Sci. Rep., 7, 2017, 44750.
23. Mukherjee, S.P., Lozano, N., Kucki, M., Del Rio-Castillo, A.E., Newman, L., Vázquez, E., Kostarelos, K., Wick, P., Fadeel, B., Detection of endotoxin contamination of graphene based materials using the TNF-α expression test and guidelines for endotoxin-free graphene oxide production. PLoS One, 11, 2016, e0166816.
24. Schwarz, H., Schmittner, M., Duschl, A., Horejs-Hoeck, J., Residual endotoxin contaminations in recombinant proteins are sufficient to activate human CD1c+ dendritic cells. PLoS One, 9, 2014, e113840.
25. Li, Y., Italiani, Y.P., Casals, E., Valkenborg, D., Mertens, I., Baggerman, G., Nelissen, I., Puntes, V., Boraschi, D., Assessing the immunosafety of engineered nanoparticles with a novel in vitro model based on human primary monocytes. ACS Appl. Mater. Interfaces, 2016 (epub ahead of print).
26. Triantafilou, M., Triantofilou, K., Lipopolysaccharide recognition: CD14 TLRs and the LPS-activation cluster. Trends Immunol. 23 (2002), 301–304.
27. Kayagaki, N., Warming, S., Lamkanfi, M., Vande Walle, L., Louie, S., Dong, J., Newton, K., Qu, Y., Liu, J., Heldens, S., Zhang, J., Lee, W.P., Roose-Girma, M., Dixit, V.M., Non-canonical inflammasome activation targets caspase-11. Nature 479 (2011), 117–121.
28. Kayagaki, N., Wong, M.T., Stowe, I.B., Ramani, S.R., Gonzalez, L.C., Akashi-Takamura, S., Miyake, K., Zhang, J., Lee, W.P., Muszyński, A., Forsberg, L.S., Carlson, R.W., Dixit, V.M., Noncanonical inflammasome activation by intracellular LPS independent of TLR4. Science 341 (2013), 1246–1249.
29. Hagar, J.A., Powell, D.A., Aachoui, Y., Ernst, R.K., Miao, E.A., Cytoplasmic LPS activates caspase-11: implications in TLR4-independent endotoxic shock. Science 341 (2013), 1250–1253.
30. Yang, J., Zhao, Y., Shao, F., Non-canonical activation of inflammatory caspases by cytosolic LPS in innate immunity. Curr. Opin. Immunol. 32 (2015), 78–83.
31. Opal, S.M., Laterre, P.F., Francois, B., LaRosa, S.P., Angus, D.C., Mira, J.P., Wittebole, X., Dugernier, T., Perrotin, D., Tidswell, M., Jauregui, L., Krell, K., Pachl, J., Takahashi, T., Peckelsen, C., Cordasco, E., Chang, C.S., Oeyen, S., Aikawa, N., Maruyama, T., Schein, R., Kalil, A.C., Van Nuffelen, M., Lynn, M., Rossignol, D.P., Gogate, J., Roberts, M.B., Wheeler, J.L., Vincent, J.L., Study Group, A.C.C.E.S.S., Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA 309 (2013), 1154–1162.
32. Martinon, F., Tschopp, J., Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 117 (2004), 561–574.
33. Gay, N.J., Symmons, M.F., Gangloff, M., Bryant, C.E., Assembly and localization of Toll-like receptor signalling complexes. Nat. Rev. Immunol. 14 (2014), 546–558.
34. Liston, A., Masters, S.L., Homeostasis-altering molecular processes as mechanisms of inflammasome activation. Nat. Rev. Immunol. 17 (2017), 208–214.
35. Fadeel, B., Clear and present danger? Engineered nanoparticles and the immune system. Swiss Med. Wkly., 142, 2012, w13609.
36. Broz, P., Dixit, V.M., Inflammasomes: mechanism of assembly, regulation and signalling. Nat. Rev. Immunol. 16 (2016), 407–420.
37. Farrera, C., Fadeel, B., It takes two to tango: understanding the interactions between engineered nanomaterials and the immune system. Eur. J. Pharm. Biopharm. 95A (2015), 3–12.
38. Jorch, S.K., Kubes, P., An emerging role for neutrophil extracellular traps in noninfectious disease. Nat. Med. 23 (2017), 279–287.
39. Bhattacharya, K., Andón, F.T., El-Sayed, R., Fadeel, B., Mechanisms of carbon nanotube-induced toxicity: focus on pulmonary inflammation. Adv. Drug Deliv. Rev. 65 (2013), 2087–2097.
40. Braakhuis, H.M., Park, M.V., Gosens, I., De Jong, W.H., Cassee, F.R., Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part. Fibre Toxicol., 11, 2014, 18.
41. Landsiedel, R., Sauer, U.G., Ma-Hock, L., Schnekenburger, J., Wiemann, M., Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. Nanomedicine (Lond.) 9 (2014), 2557–2585.
42. Cho, W.S., Duffin, R., Poland, C.A., Howie, S.E., MacNee, W., Bradley, M., Megson, I.L., Donaldson, K., Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ. Health Perspect. 118 (2010), 1699–1706.
43. Cho, W.S., Duffin, R., Poland, C.A., Duschl, A., Oostingh, G.J., MacNee, W., Bradley, M., Megson, I.L., Donaldson, K., Differential pro-inflammatory effects of metal oxide nanoparticles and their soluble ions in vitro and in vivo; zinc and copper nanoparticles, but not their ions, recruit eosinophils to the lungs. Nanotoxicology 6 (2012), 22–35.
44. Gustafsson, Å., Lindstedt, E., Elfsmark, L.S., Bucht, A., Lung exposure of titanium dioxide nanoparticles induces innate immune activation and long-lasting lymphocyte response in the Dark Agouti rat. J. Immunotoxicol. 8 (2011), 111–121.
45. Scoville, D.K., White, C.C., Botta, D., McConnachie, L.A., Zadworny, M.E., Schmuck, S.C., Hu, X., Gao, X., Yu, J., Dills, R.L., Sheppard, L., Delaney, M.A., Griffith, W.C., Beyer, R.P., Zangar, R.C., Pounds, J.G., Faustman, E.M., Kavanagh, T.J., Susceptibility to quantum dot induced lung inflammation differs widely among the collaborative cross founder mouse strains. Toxicol. Appl. Pharmacol. 289 (2015), 240–250.
46. Gustafsson, Å., Bergström, U., Ågren, L., Österlund, L., Sandström, T., Bucht, A., Differential cellular responses in healthy mice and in mice with established airway inflammation when exposed to hematite nanoparticles. Toxicol. Appl. Pharmacol. 288 (2015), 1–11.
47. Rossi, E.M., Pylkkänen, L., Koivisto, A.J., Nykäsenoja, H., Wolff, H., Savolainen, K., Alenius, H., Inhalation exposure to nanosized and fine TiO2 particles inhibits features of allergic asthma in a murine model. Part. Fibre Toxicol., 7, 2015, 35.
48. Donaldson, K., Poland, C.A., Murphy, F.A., MacFarlane, M., Chernova, T., Schinwald, A., Pulmonary toxicity of carbon nanotubes and asbestos – similarities and differences. Adv. Drug Deliv. Rev. 65 (2013), 2078–2086.
49. Shvedova, A.A., Kisin, E.R., Mercer, R., Murray, A.R., Johnson, V.J., Potapovich, A.I., Tyurina, Y.Y., Gorelik, O., Arepalli, S., Schwegler-Berry, D., Hubbs, A.F., Antonini, J., Evans, D.E., Ku, B.K., Ramsey, D., Maynard, A., Kagan, V.E., Castranova, V., Baron, P., Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 289 (2005), L698–L708.
50. Shvedova, A.A., Kisin, E.R., Murray, A.R., Johnson, V.J., Gorelik, O., Arepalli, S., Hubbs, A.F., Mercer, R., Keohavong, P., Sussman, N., Jin, J., Yin, J., Stone, S., Chen, B.T., Deye, G., Maynard, A., Castranova, V., Baron, P., Kagan, V.E., Inhalation vs. aspiration of single-walled carbon nanotubes in C57BL/6 mice: inflammation, fibrosis, oxidative stress, and mutagenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. 295 (2008), L552–L565.
51. Poland, C.A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W.A., Seaton, A., Stone, V., Brown, S., Macnee, W., Donaldson, K., Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat. Nanotechnol. 3 (2008), 423–428.
52. Rydman, E.M., Ilves, M., Koivisto, A.J., Kinaret, P.A., Fortino, V., Savinko, T.S., Lehto, M.T., Pulkkinen, V., Vippola, M., Hämeri, K.J., Matikainen, S., Wolff, H., Savolainen, K.M., Greco, D., Alenius, H., Inhalation of rod-like carbon nanotubes causes unconventional allergic airway inflammation. Part. Fibre Toxicol., 11, 2014, 48.
53. Katwa, P., Wang, X., Urankar, R.N., Podila, R., Hilderbrand, S.C., Fick, R.B., Rao, A.M., Ke, P.C., Wingard, C.J., Brown, J.M., A carbon nanotube toxicity paradigm driven by mast cells and the IL-33/ST2 axis. Small 8 (2012), 2904–2912.
54. Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B.T., Tschopp, J., Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320 (2008), 674–677.
55. Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L., Fitzgerald, K.A., Latz, E., Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat. Immunol. 9 (2008), 847–856.
56. Cassel, S.L., Eisenbarth, S.C., Iyer, S.S., Sadler, J.J., Colegio, O.R., Tephly, L.A., Carter, A.B., Rothman, P.B., Flavell, R.A., Sutterwala, F.S., The Nalp3 inflammasome is essential for the development of silicosis. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 9035–9040.
57. Eisenbarth, S.C., Colegio, O.R., O'Connor, W., Sutterwala, F.S., Flavell, R.A., Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453 (2008), 1122–1126.
58. Sun, B., Wang, X., Ji, Z., Li, R., Xia, T., NLRP3 inflammasome activation induced by engineered nanomaterials. Small 9 (2013), 1595–1607.
59. + efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38 (2013), 1142–1153.
60. Li, R., Ji, Z., Chang, C.H., Dunphy, D.R., Cai, X., Meng, H., Zhang, H., Sun, B., Wang, X., Dong, J., Lin, S., Wang, M., Liao, Y.P., Brinker, C.J., Nel, A., Xia, T., Surface interactions with compartmentalized cellular phosphates explain rare earth oxide nanoparticle hazard and provide opportunities for safer design. ACS Nano 8 (2014), 1771–1783.
61. Tsugita, M., Morimoto, N., Tashiro, M., Kinoshita, K., Nakayama, M., SR-B1 is a silica receptor that mediates canonical inflammasome activation. Cell Rep. 18 (2017), 1298–1311.
62. Andón, F.T., Fadeel, B., Programmed cell death: molecular mechanisms and implications for safety assessment of nanomaterials. Acc. Chem. Res. 46 (2013), 733–742.
63. Bergsbaken, T., Fink, S.L., Cookson, B.T., Pyroptosis: host cell death and inflammation. Nat. Rev. Microbiol. 7 (2009), 99–109.
64. Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., Shao, F., Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526 (2015), 660–665.
65. Kayagaki, N., Stowe, I.B., Lee, B.L., O'Rourke, K., Anderson, K., Warming, S., Cuellar, T., Haley, B., Roose-Girma, M., Phung, Q.T., Liu, P.S., Lill, J.R., Li, H., Wu, J., Kummerfeld, S., Zhang, J., Lee, W.P., Snipas, S.J., Salvesen, G.S., Morris, L.X., Fitzgerald, L., Zhang, Y., Bertram, E.M., Goodnow, C.C., Dixit, V.M., Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling. Nature 526 (2015), 666–710.
66. Reisetter, A.C., Stebounova, L.V., Baltrusaitis, J., Powers, L., Gupta, A., Grassian, V.H., Monick, M.M., Induction of inflammasome-dependent pyroptosis by carbon black nanoparticles. J. Biol. Chem. 286 (2011), 21844–21852.
67. Andón, F.T., Mukherjee, S.P., Gessner, I., Wortmann, L., Xiao, L., Hultenby, K., Shvedova, A.A., Mathur, S., Fadeel, B., Hollow carbon spheres trigger inflammasome-dependent IL-1β secretion in macrophages. Carbon 113 (2017), 243–251.
68. Chen, K.W., Bezbradica, J.S., Groß, C.J., Wall, A.A., Sweet, M.J., Stow, J.L., Schroder, K., The murine neutrophil NLRP3 inflammasome is activated by soluble but not particulate or crystalline agonists. Eur. J. Immunol. 46 (2016), 1004–1010.
69. Chen, K.W., Groß, C.J., Sotomayor, F.V., Stacey, K.J., Tschopp, J., Sweet, M.J., Schroder, K., The neutrophil NLRC4 inflammasome selectively promotes IL-1β maturation without pyroptosis during acute Salmonella challenge. Cell Rep. 8 (2014), 570–582.
70. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D.S., Weinrauch, Y., Zychlinsky, A., Neutrophil extracellular traps kill bacteria. Science 303 (2004), 1532–1535.
71. Branzk, N., Lubojemska, A., Hardison, S.E., Wang, Q., Gutierrez, M.G., Brown, G.D., Papayannopoulos, V., Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens. Nat. Immunol. 15 (2014), 1017–1025.
72. Liz, R., Simard, J.C., Leonardi, L.B., Girard, D., Silver nanoparticles rapidly induce atypical human neutrophil cell death by a process involving inflammatory caspases and reactive oxygen species and induce neutrophil extracellular traps release upon cell adhesion. Int. Immunopharmacol. 28 (2015), 616–625.
73. Hwang, T.L., Aljuffali, I.A., Hung, C.F., Chen, C.H., Fang, J.Y., The impact of cationic solid lipid nanoparticles on human neutrophil activation and formation of neutrophil extracellular traps (NETs). Chem. Biol. Interact. 235 (2015), 106–114.
74. Muñoz, L.E., Bilyy, R., Biermann, M.H., Kienhöfer, D., Maueröder, C., Hahn, J., Brauner, J.M., Weidner, D., Chen, J., Scharin-Mehlmann, M., Janko, C., Friedrich, R.P., Mielenz, D., Dumych, T., Lootsik, M.D., Schauer, C., Schett, G., Hoffmann, M., Zhao, Y., Herrmann, M., Nanoparticles size-dependently initiate self-limiting NETosis-driven inflammation. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E5856–E5865.
75. S.P. Mukherjee, B. Lazzaretto, K. Hultenby, L. Newman, A.F. Rodrigues, N. Lozano, K. Kostarelos, P. Malmberg, B. Fadeel, Probing graphene oxide-induced plasma membrane perturbations in neutrophils using time-of-flight secondary ion mass spectroscopy, Chem. [under revision].
76. Farrera, C., Bhattacharya, K., Lazzaretto, B., Andón, F.T., Hultenby, K., Kotchey, G.P., Star, A., Fadeel, B., Extracellular entrapment and degradation of single-walled carbon nanotubes. Nanoscale 6 (2014), 6974–6983.
77. S.P. Mukherjee, A.R. Gliga, B. Lazzaretto, B. Brandner, M. Fielden, L. Newman, A.F. Rodrigues, W. Shao, P.M. Fournier, A. Star, K. Kostarelos, K. Bhattacharya, B. Fadeel, Graphene oxide is degraded by neutrophils and the degradation products are non-genotoxic, Nanoscale [under revision].
78. Mukherjee, S.P., Bottini, M., Fadeel, B., Graphene and the immune system: a romance of many dimensions. Front. Immunol., 8, 2017, 673.
79. Grosse, Y., Loomis, D., Guyton, K.Z., Lauby-Secretan, B., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Scoccianti, C., Mattock, H., Straif, K., International Agency for Research on Cancer Monograph Working Group, Carcinogenicity of fluoro-edenite, silicon carbide fibres and whiskers, and carbon nanotubes. Lancet Oncol. 15 (2014), 1427–1428.
80. Vlasova, I.I., Kapralov, A.A., Michael, Z.P., Burkert, S.C., Shurin, M.R., Star, A., Shvedova, A.A., Kagan, V.E., Enzymatic oxidative biodegradation of nanoparticles: mechanisms, significance and applications. Toxicol. Appl. Pharmacol. 299 (2016), 58–69.
81. Russier, J., Ménard-Moyon, C., Venturelli, E., Gravel, E., Marcolongo, G., Meneghetti, M., Doris, E., Bianco, A., Oxidative biodegradation of single- and multi-walled carbon nanotubes. Nanoscale 3 (2011), 893–896.
82. Kagan, V.E., Konduru, N.V., Feng, W., Allen, B.L., Conroy, J., Volkov, Y., Vlasova, I.I., Belikova, N.A., Yanamala, N., Kapralov, A.A., Tyurina, Y.Y., Shi, J., Kisin, E.R., Murray, A.R., Franks, J., Stolz, D., Gou, P., Klein-Seetharaman, J., Fadeel, B., Star, A., Shvedova, A.A., Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. Nat. Nanotechnol. 5 (2010), 354–359.
83. Shvedova, A.A., Kapralov, A.A., Feng, W.H., Kisin, E.R., Murray, A.R., Mercer, R.R., St Croix, C.M., Lang, M.A., Watkins, S.C., Konduru, N.V., Allen, B.L., Conroy, J., Kotchey, G.P., Mohamed, B.M., Meade, A.D., Volkov, Y., Star, A., Fadeel, B., Kagan, V.E., Impaired clearance and enhanced pulmonary inflammatory/fibrotic response to carbon nanotubes in myeloperoxidase-deficient mice. PLoS One, 7, 2012, e30923.
84. Andón, F.T., Kapralov, A.A., Yanamala, N., Feng, W., Baygan, A., Chambers, B.J., Hultenby, K., Ye, F., Toprak, M.S., Brandner, B.D., Fornara, A., Klein-Seetharaman, J., Kotchey, G.P., Star, A., Shvedova, A.A., Fadeel, B., Kagan, V.E., Biodegradation of single-walled carbon nanotubes by eosinophil peroxidase. Small 9 (2013), 2721–2729.
85. Sureshbabu, A.R., Kurapati, R., Russier, J., Ménard-Moyon, C., Bartolini, I., Meneghetti, M., Kostarelos, K., Bianco, A., Degradation-by-design: surface modification with functional substrates that enhance the enzymatic degradation of carbon nanotubes. Biomaterials 72 (2015), 20–28.
86. Ginhoux, F., Jung, S., Monocytes and macrophages: development pathways and tissue homeostasis. Nat. Rev. Immunol. 14 (2014), 392–404.
87. Epelman, S., Lavine, K.J., Randolph, G.J., Origin and functions of tissue macrophages. Immunity 41 (2014), 21–35.
88. Wynn, T.A., Chawla, A., Pollard, J.W., Macrophage biology in development, homeostasis, and disease. Nature 496 (2013), 445–455.
89. Italiani, P., Boraschi, D., From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front. Immunol., 5, 2014, 514.
90. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M., The chemokines system in diverse forms of macrophage activation and polarization. Trends Immunol. 25 (2004), 677–686.
91. Gordon, S., Plüddemann, A., Martinez Estrada, F., Macrophage heterogeneity in tissues: phenotypic diversity and functions. Immunol. Rev. 262 (2014), 36–55.
92. Noy, R., Pollard, W.J., Tumor-associated macrophages: from mechanisms to therapy. Immunity 41 (2014), 49–61.
93. Tamoutounour, S., Guilliams, M., Montanana Sanchis, F., Liu, H., Terhorst, D., Malosse, C., Pollet, E., Ardouin, L., Luche, H., Sanchez, C., Dalod, M., Malissen, B., Henri, S., Origins and functional specialization of macrophages and of conventional and monocyte-derived dendritic cells in mouse skin. Immunity 39 (2013), 925–938.
94. Varol, C., Mildner, A., Jung, S., Macrophages: development and tissue specialization. Annu. Rev. Immunol. 33 (2015), 643–675.
95. Ginhoux, F., Guilliams, M., Tissue-resident macrophage ontogeny and homeostasis. Immunity 44 (2016), 439–449.
96. Fejer, G., Sharma, S., Gyory, I., Self-renewing macrophages–a new line of enquiries in mononuclear phagocytes. Immunobiology 220 (2015), 169–174.
97. Martinez, F.O., Regulators of macrophage activation. Eur. J. Immunol. 41 (2011), 1531–1534.
98. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 (2002), 549–555.
99. Brown, J.M., Recht, L., Strober, S., The promise of targeting macrophages in cancer therapy. Clin. Cancer Res. 23 (2017), 3241–3250.
100. Hoppstädter, J., Seif, M., Dembek, A., Cavelius, C., Huwer, H., Kraegeloh, A., Kiemer, A.K., M2 polarization enhances silica nanoparticle uptake by macrophages. Front. Pharmacol., 6, 2015, 55.
101. Miao, X., Leng, X., Zhang, Q., The current state of nanoparticle-induced macrophage polarization and reprogramming research. Int. J. Mol. Sci., 18, 2017 pii: E336.
102. Yen, H., Hsu, S., Tsai, C., Cytotoxicity and immunological response of gold and silver nanoparticles of different sizes. Small 5 (2009), 1553–1561.
103. Nishanth, R.P., Jyotsna, R.G., Schlager, J.J., Hussain, S.M., Reddanna, P., Inflammatory responses of RAW264.7 macrophages upon exposure to nanoparticles: role of ROS-NFkB signaling pathway. Nanotoxicology 5 (2011), 502–516.
104. Hashimoto, M., Toshima, H., Yonezawa, T., Kawai, K., Narushima, T., Kaga, M., Endo, K., Responses of RAW264.7 macrophages to water-dispersible gold and silver nanoparticles stabilized by metal-carbon sigma-bonds. J. Biomed. Mater. Res. A 102 (2014), 1838–1849.
105. Zhang, Q., Hitchins, V.M., Schrand, A.M., Hussain, S.M., Goering, P.L., Uptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediators. Nanotoxicity 5 (2011), 284–295.
106. Giovanni, M., Yue, J., Zhang, L., Xie, J., Ong, C.N., Leong, D.T., Pro-inflammatory responses of RAW264.7 macrophages when treated with ultralow concentrations of silver titanium dioxide, and zinc oxide nanoparticles. J. Hazard. Mater. 297 (2015), 146–152.
107. Zanganeh, S., Hutter, G., Spitler, R., Lenkov, O., Mahmoudi, M., Shaw, A., Pajarinen, J.S., Nejadnik, H., Goodman, S., Moseley, M., Coussens, L.M., Daldrup-Link, H.E., Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues. Nat. Nanotechnol. 11 (2016), 986–994.
108. Lucarelli, M., Gatti, A.M., Savarino, G., Quattroni, P., Martinelli, L., Monari, E., Boraschi, D., Innate defence functions of macrophages can be biased by nano-sized ceramic and metallic particles. Eur. Cytokine Netw. 15 (2004), 339–346.
109. Ma, J., Liu, R., Wang, X., Liu, Q., Chen, Y., Valle, R.P., Zuo, Y.Y., Xia, T., Liu, S., Crucial role of lateral size for graphene oxide in activating macrophages and stimulating pro-inflammatory responses in cells and animals. ACS Nano 9 (2015), 10498–10515.
110. Gallud, A., Bondarenko, O., Feliu, N., Kupferschmidt, N., Atluri, R., Garcia-Bennett, A., Fadeel, B., Macrophage activation status determines the internalization of mesoporous silica particles of different sizes: exploring the role of different pattern recognition receptors. Biomaterials 121 (2017), 28–40.
111. Jones, S.W., Roberts, R.A., Robbins, G.R., Perry, J.L., Kai, M.P., Chen, K., Bo, T., Napier, M.E., Ting, J.P., Desimone, J.M., Bear, J.E., Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J. Clin. Invest. 123 (2013), 3061–3073.
112. MacParland, S.A., Tsoi, K.M., Ouyang, B., Ma, X.Z., Manuel, J., Fawaz, A., Ostrowski, M.A., Alman, B.A., Zilman, A., Chan, W.C., McGilvray, I.D., Phenotype determines nanoparticle uptake by human macrophages from liver and blood. ACS Nano 11 (2017), 2428–2443.
113. Laskar, A., Eilertsen, J., Li, W., Yuan, X.M., SPION primes THP1 derived M2 macrophages towards M1-like macrophages. Biochem. Biophys. Res. Commun. 441 (2013), 737–742.
114. Su, L., Zhang, W., Wu, X., Zhang, Y., Chen, X., Liu, G., Chen, G., Jiang, M., Glycocalyx-mimicking nanoparticles for stimulation and polarization of macrophages via specific interactions. Small 11 (2015), 4191–4200.
115. Perisé-Barrios, A.J., Gómez, R., Corbí, A.L., de la Mata, J., Domínguez-Soto, A., Muñoz-Fernandez, M.A., Use of carbosilane dendrimer to switch macrophage polarization for the acquisition of antitumor functions. Nanoscale 7 (2015), 3857–3866.
116. Kwon, D., Cha, B.G., Cho, Y., Min, J., Park, E.-B., Kang, S.-J., Kim, J., Extra-large pore mesoporous silica nanoparticles for directing in vivo M2 macrophage polarization by delivering IL-4. Nano Lett. 17 (2017), 2747–2756.
117. Tran, T., Rastogi, R., Shelke, J., Amiji, M.M., Modulation of macrophage functional polarity towards anti-inflammatory phenotype with plasmid DNA delivery in CD44 targeting hyaluronic acid nanoparticles. Sci. Rep., 5, 2015, 16632.
118. Tran, T., Krishnan, S., Amiji, M.M., MicroRNA-223 induced repolarization of peritoneal macrophages using CD44 targeting hyaluronic acid nanoparticles for anti-inflammatory effects. PLoS One, 11, 2016, e152024.
119. Binnemars-Postma, K., Storm, G., Prakash, J., Nanomedicine strategies to target tumor-associated macrophages. Int. J. Mol. Sci., 18, 2017 pii: E979.
120. Leonard, F., Curtis, L.T., Ware, M.J., Nosrat, T., Liu, X., Yokoi, K., Frieboes, H.B., Godin, B., Macrophage polarization contributes to the anti-tumoral efficacy of mesoporous nanovectors loaded with albumin-bound paclitaxel. Front. Immunol., 8, 2017, 693.
121. Espinas, N.A., Saze, H., Saijo, Y., Epigenetic control of defense signaling and priming in plants. Front. Plant Sci., 7, 2016, 1201.
122. Kurtz, J., Specific memory within innate immune systems. Trends Immunol. 26 (2005), 186–192.
123. Netea, M.G., Joosten, L.A., Latz, E., Mills, K.H., Natoli, G., Stunnenberg, H.G., O'Neill, L.A., Xavier, R.J., Trained immunity: a program of innate immune memory in health and disease. Science, 352, 2016 aaf1098.
124. Morris, M.C., Gilliam, E.A., Li, L., Innate immune programming by endotoxin and its pathological consequences. Front. Immunol., 5, 2015, 680.
125. Boyoglu, C., Boyoglu-Barnum, S., Soni, S., He, Q., Willing, G., Miller, M., Singh, S., The intracellular co-localizations of different size of gold nanoparticles. Nanotechnology 2011: Bio Sensors, Instruments, Medical, Environment and Energy, 2012, Nano Science and Technology Institute, Austin, 489–492.
126. Carriere, M., Sauvaigo, S., Douki, T., Ravanat, J.L., Impact of nanoparticles on DNA repair processes: current knowledge and working hypotheses. Mutagenesis 32 (2017), 203–213.
127. Durnev, A.D., Toxicology of nanoparticles. Bull. Exp. Biol. Med. 145 (2008), 72–74.
128. Singh, N., Manshian, B., Jenkins, G.J., Griffiths, S.M., Williams, P.M., Maffeis, T.G., Wright, C.J., Doak, S.H., NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials. Biomaterials 28 (2009), 2946–2958.
129. Mytych, J., Maciej, W., Nanoparticle technology as a double-edged sword: cytotoxic, genotoxic and epigenetic effects on living cells. J. Biomater. Nanobiotechnol. 4 (2013), 53–63.
130. Yao, Y., Costa, M., Genetic and epigenetic effects of nanoparticles. J. Mol. Genet. Med., 7, 2013, 86.
131. Sierra, M.I., Valdès, A., Fernàndez, A.F., Torrecillas, R., Fraga, M.F., The effect of exposure to nanoparticles and nanomaterials on the mammalian epigenome. Int. J. Nanomed. 11 (2016), 6297–6306.
132. Stoccoro, A., Karlsson, H.L., Coppedè, F., Migliore, L., Epigenetic effects of nano-sized materials. Toxicology 313 (2013), 3–14.
133. Conroy, J., Byrne, S.J., Gun'ko, Y.K., Rakovich, Y.P., Donegan, J.F., Davies, A., Kelleher, D., Volkov, Y., CdTe nanoparticles display tropism to core histones and histone-rich cell organelles. Small 4 (2008), 2006–2015.
134. Lu, X., Miousse, I.R., Pirela, S.V., Melnyk, S., Koturbash, I., Demokritou, P., Short-term exposure to engineered nanomaterials affects cellular epigenome. Nanotoxicology 10 (2016), 140–150.
135. Baccarelli, A., Wright, R.O., Bollati, V., Tarantini, L., Litonjua, A.A., Suh, H.H., Zanobetti, A., Sparrow, D., Vokonas, P.S., Schwartz, J., Rapid DNA methylation changes after exposure to traffic particles. Am. J. Respir. Crit. Care Med. 179 (2009), 572–578.
136. Madrigano, J., Baccarelli, A., Mittleman, M.A., Wright, R.O., Sparrow, D., Vokonas, P.S., Tarantini, L., Schwartz, J., Prolonged exposure to particulate pollution genes associated with glutathione pathways, and DNA methylation in a cohort of older men. Environ. Health Perspect. 119 (2011), 977–982.
137. Bind, M.A., Baccarelli, A., Zanobetti, A., Tarantini, L., Suh, H., Vokonas, P.S., Schwartz, J., Air pollution and markers of coagulation inflammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort. Epidemiology 23 (2012), 332–340.
138. Italiani, P., Boraschi, D., Induction of innate immune memory by engineered nanoparticles: a hypothesis that may become true. Front. Immunol., 8, 2017, 734.
139. Chiariotti, L., Coretti, L., Pero, R., Lembo, F., Epigenetic alterations induced by bacterial lipopolysaccharides. Adv. Exp. Med. Biol. 879 (2016), 91–105.
140. Milling, L., Zhang, Y., Irvine, D.J., Delivering safer immunotherapies for cancer. Adv. Drug Deliv. Rev., 2017, 10.1016/j.addr.2017.05.011 pii: S0169-409X(17)30067-4, Epub ahead of print.
141. Velpurisiva, P., Gad, A., Piel, B., Jadia, R., Rai, P., Nanoparticle design strategies for effective cancer immunotherapy. J. Biomed. (Syd.) 2 (2017), 64–77.
142. Dimitriou, N.M., Tsekenis, G., Balanikas, E.C., Pavlopoulou, A., Mitsiogianni, M., Mantso, T., Pashos, G., Boudouvis, A.G., Lykakis, I.N., Tsigaridas, G., Panayiotidis, M.I., Yannopapas, V., Georgakilas, A.G., Gold nanoparticles, radiations and the immune system: current insights into the physical mechanisms and the biological interactions of this new alliance towards cancer therapy. Pharmacol. Ther., 2017, 10.1016/j.pharmthera.2017.03.006 pii: S0163-7258(17)30086-4, Epub ahead of print.
143. Gutjahr, A., Tiraby, G., Perouzel, E., Verrier, B., Paul, S., Triggering intracellular receptors for vaccine adjuvantation. Trends Immunol. 37 (2016), 573–587.
144. Taki, A., Smooker, P., Small wonders-the use of nanoparticles for delivering antigen. Vaccines (Basel) 3 (2015), 638–661.
145. Boraschi, D., Italiani, P., From antigen delivery system to adjuvanticy: the board application of nanoparticles in vaccinology. Vaccines (Basel) 3 (2015), 930–939.
146. Steinhagen, F., Rodriguez, L.G., Tross, D., Tewary, P., Bode, C., Klinman, D.M., IRF5 and IRF8 modulate the CAL-1 human plasmacytoid dendritic cell line response following TLR9 ligation. Eur. J. Immunol. 46 (2016), 647–655.
147. Hilbert, T., Steinhagen, F., Weisheit, C., Baumgarten, G., Hoeft, A., Klaschik, S., Synergistic stimulation with different TLR7 ligands modulates gene expression patterns in the human plasmacytoid dendritic cell Line CAL-1. Mediators Inflamm., 2015, 2015, 948540.
148. Armitage, C.W., O'Meara, C.P., Beagley, K.W., Chlamydia pneumoniae and Chlamydia trachomatis infection differentially modulates human dendritic cell Line (MUTZ) differentiation and activation. Scand. J. Immunol. 82 (2015), 48–54.
149. Kadengodlu, P.A., Hebishima, T., Takeshima, S.N., Ito, M., Liu, M., Abe, H., Aida, Y., Aigaki, T., Ito, Y., Positively charged cholesterol-recombinant human gelatins foster the cellular uptake of proteins and murine immune reactions. Int. J. Nanomed. 7 (2012), 5437–5450.
150. Ssemakalu, C.C., Ubomba-Jaswa, E., Motaung, K.S., Pillay, M., The effect of solar irradiated Vibrio cholerae on the secretion of pro-inflammatory cytokines and chemokines by the JAWS II dendritic cell line in vitro. PLoS One, 10, 2015, e0130190.
151. Horev-Azaria, L., Baldi, G., Beno, D., Bonacchi, D., Golla-Schindler, U., Kirkpatrick, J.C., Kolle, S., Landsiedel, R., Maimon, O., Marche, P.N., Ponti, J., Romano, R., Rossi, F., Sommer, D., Uboldi, C., Unger, R.E., Villiers, C., Korenstein, R., Predictive toxicology of cobalt ferrite nanoparticles: comparative in-vitro study of different cellular models using methods of knowledge discovery from data. Part. Fibre Toxicol., 10, 2013, 32.
152. Tomić, S., ðokić, J., Vasilijić, S., Ogrinc, N., Rudolf, R., Pelicon, P., Vučević, D., Milosavljević, P., Janković, S., Anžel, I., Rajković, J., Rupnik, M.S., Friedrich, B., Colić, M., Size-dependent effects of gold nanoparticles uptake on maturation and antitumor functions of human dendritic cells in vitro. PLoS One, 9, 2014, e96584.
153. Fernández, T.D., Pearson, J.R., Leal, M.P., Torres, M.J., Blanca, M., Mayorga, C., Le Guével, X., Intracellular accumulation and immunological properties of fluorescent gold nanoclusters in human dendritic cells. Biomaterials 243 (2015), 1–12.
154. Fytianos, K., Rodriguez-Lorenzo, L., Clift, M.J., Blank, F., Vanhecke, D., von Garnier, C., Petri-Fink, A., Rothen-Rutishauser, B., Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine 1 (2015), 633–644.
155. Paik, S.Y., Kim, J.S., Shin, S.J., Ko, S., Characterization quantification, and determination of the toxicity of iron oxide nanoparticles to the bone marrow cells. Int. J. Mol. Sci. 16 (2015), 22243–22257.
156. Margaroni, M., Agallou, M., Kontonikola, K., Karidi, K., Kammona, O., Kiparissides, C., Gaitanaki, C., Karagouni, E., PLGA nanoparticles modified with a TNFα mimicking peptide, soluble Leishmania antigens and MPLA induce T cell priming in vitro via dendritic cell functional differentiation. Eur. J. Pharm. Biopharm. 105 (2016), 18–31.
157. Barbosa, J.P., Neves, A.R., Silva, A.M., Barbosa, M.A., Reis, M.S., Santos, S.G., Nanostructured lipid carriers loaded with resveratrol modulate human dendritic cells. Int. J. Nanomed. 11 (2016), 3501–3516.
158. Piazza, M., Colombo, M., Zanoni, I., Granucci, F., Tortora, P., Weiss, J., Gioannini, T., Prosperi, D., Peri, F., Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling. Angew. Chem. Int. Ed. Engl. 50 (2011), 622–626.
159. Nakanishi, K., Tsukimoto, M., Tanuma, S., Takeda, K., Kojima, S., Silica nanoparticles activate purinergic signaling via P2 × 7 receptor in dendritic cells, leading to production of pro-inflammatory cytokines. Toxicol. In Vitro 35 (2016), 202–211.
160. Reddy, S.T., Swartz, M.A., Hubbell, J.A., Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol. 27 (2006), 573–579.
161. Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., Bachmann, M.F., Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38 (2008), 1404–1413.
162. Demento, S.L., Eisenbarth, S.C., Foellmer, H.G., Platt, C., Caplan, M.J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R.A., Fahmy, T.M., Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy. Vaccine 27 (2009), 3013–3021.
163. Wang, C., Li, P., Liu, L., Pan, H., Li, H., Cai, L., Ma, Y., Self-adjuvanted nanovaccine for cancer immunotherapy: role of lysosomal rupture-induced ROS in MHC class I antigen presentation. Biomaterials 79 (2016), 88–100.
164. Gao, J., Ochyl, L.J., Yang, E., Moon, J.J., Cationic liposomes promote antigen cross-presentation in dendritic cells by alkalizing the lysosomal pH and limiting the degradation of antigens. Int. J. Nanomed. 12 (2017), 1251–1264.
165. Seydoux, E., Rothen-Rutishauser, B., Nita, I.M., Balog, S., Gazdhar, A., Stumbles, P.A., Petri-Fink, A., Blank, F., von Garnier, C., Size-dependent accumulation of particles in lysosomes modulates dendritic cell function through impaired antigen degradation. Int. J. Nanomed. 9 (2017), 3885–3902.
166. Holers, V.M., Complement and its receptors: new insights into human disease. Annu. Rev. Immunol. 32 (2014), 433–459.
167. Sjöberg, A.P., Trouw, L.A., Blom, A.M., Complement activation and inhibition: a delicate balance. Trends Immunol. 30 (2009), 83–90.
168. Ricklin, D., Hajishengallis, G., Yang, K., Lambris, J.D., Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11 (2010), 785–797.
169. Wibroe, P.P., Helvig, S.Y., Moghimi, S.M., The role of complement in antibody therapy for infectious diseases. Microbiol. Spectrum, 2, 2014, 10.1128/microbiolspec.aid-0015-2014.
170. Moghimi, S.M., Cancer nanomedicine and the complement system activation paradigm: anaphylaxis and tumour growth. J. Controlled Release 190 (2014), 556–562.
171. Farhangrazi, Z.S., Moghimi, S.M., Materials etiquette and complement responses. Curr. Bionanotechnol. 2 (2016), 6–10.
172. Moghimi, S.M., Parhamifar, L., Ahmadvand, D., Wibroe, P.P., Andresen, T.L., Farhangrazi, Z.S., Hunter, A.C., Particulate systems for targeting of macrophages: basic and therapeutic concepts. J. Innate Immun. 4 (2012), 509–528.
173. Cornacoff, J.B., Hebert, L.A., Smead, W.L., Van Aman, M.E., Birmingham, D.J., Waxman, F.J., Primate erythrocyte-immune complex-bearing mechanism. J. Clin. Invest. 71 (1983), 236–247.
174. Loughrey, H.C., Bally, M.B., Reinish, L.W., Cullis, P., The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement. Thromb. Haemost. 64 (1990), 172–176.
175. Moghimi, S.M., Complement propriety and conspiracy in nanomedicine: perspective and a hypothesis. Nucleic Acid Ther. 26 (2016), 67–72.
176. Wibroe, P.P., Anselmo, A.C., Nilsson, P.H., Sarode, A., Gupta, V., Urbanics, R., Szebeni, J., Hunter, A.C., Mitragotri, S., Mollnes, T.E., Moghimi, S.M., Bypassing adverse injection reactions to nanoparticles through shape modification and attachment to erythrocytes. Nat. Nanotechnol. 12 (2017), 589–594.
177. Moghimi, S.M., Farhangrazi, Z.S., Just so stories: the random act of anti-cancer nanomedicine performance. Nanomedicine 10 (2014), 1661–1666.
178. Guglietta, S., Rascigno, M., hypercoagulation and complement: connected players in tumor development and metastases. Semin. Immunol. 28 (2016), 578–586.
179. Hattori, R., Hamilton, K.K., McEver, R.P., Sims, P.J., Complement proteins C5b-9 induce secretion of high molecular-weight multimers of endothelial von Willebrand-factor and translocation of granule membrane-protein GMP-140 to the cell-surface. J. Biol. Chem. 264 (1989), 9053–9060.
180. Moghimi, S.M., Andersen, A.J., Ahmadvand, D., Wibroe, P.P., Andresen, T.L., Hunter, A.C., Material properties in complement activation. Adv. Drug Deliv. Rev. 63 (2011), 1000–1007.
181. Hamad, I., Al-Hanbali, O., Hunter, A.C., Rutt, K.J., Andresen, T.L., Moghimi, S.M., Distinct polymer architecture mediates switching of complement activation pathways at the nanosphere-serum interface: implications for stealth nanoparticle engineering. ACS Nano 4 (2010), 6629–6638.
182. Salvador-Morales, C., Flahaut, E., Sim, E., Sloan, J., Green, M., Sim, R.B., Complement activation and protein adsorption by carbon nanotubes. Mol. Immunol. 43 (2006), 193–201.
183. Pondman, K.M., Sobik, M., Nayak, A., Tsolaki, A.G., Jäkel, A., Flahaut, E., Hampel, S., ten Haken, B., Sim, R.B., Kishore, U., Complement activation by carbon nanotubes and its influence on the phagocytosis and cytokine response by macrophages. Nanomedicine 10 (2014), 1287–1299.
184. Moghimi, S.M., Hunter, A.C., Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm. Res. 18 (2001), 1–8.
185. Wang, G., Griffin, J.I., Inturi, S., Brenneman, B., Banda, N.K., Holers, V.M., Moghimi, S.M., Simberg, D., In vitro and in vivo differences in murine third complement component (C3) opsonisation and macrophages/leukocyte responses to antibody-functionalized iron oxide nanoworms. Front. Immunol., 8, 2017, 151.
186. Feinstein, A., Richardson, N., Taussig, M.J., Immunoglobulin flexibility in complement activation. Immunol. Today 7 (1986), 169–174.
187. Strumane, M.A., Lindorfer, M., Voorhorst, D., Ugurlar, S., Rosati, A.J.R., Heck van de Winkel, J.G.J., Wilson, I.A., Koster, A.J., Taylor, R.P., Saphire, E.O., Burton, D.R., Schuurman, J., Gros, P., Parren, P.W.H.I., Complement is activated by Igg hexamers assembled at the cell surface. Science 343 (2014), 1260–1263.
188. Feinstein, A., Munn, E.A., Conformation of the free and antigen-bound IgM antibody molecules. Nature 224 (1969), 1307–1309.
189. Pedersen, M.B., Zhou, X., Larsen, E.K., Sorensen, U.S., Kjems, J., Nygaard, J.V., Nyengaard, J.R., Meyer, R.L., Boesen, T., Vorup-Jensen, T., Curvature of synthetic and natural surfaces is an important target feature in classical pathway complement activation. J. Immunol. 184 (2010), 1931–1945.
190. Wibroe, P.P., Petersen, S.V., Bovet, N., Moghimi, S.M., Soluble and immobilized graphene oxide activates complement system differently dependent on surface oxidation state. Biomaterials 78 (2016), 20–26.
191. Whitehead, B., Wu, L., Hvam, M.L., Aslan, H., Dong, M., Dyrskjøt, L., Ostenfeld, M.S., Moghimi, S.M., Howard, K.A., Tumour exosomes display differential mechanical and complement activation properties dependent on malignant state: implications in endothelial leakiness. J. Extracell. Vesicles, 4, 2015, 29685.
192. Clayton, A., Harris, C.L., Court, J., Mason, M.D., Morgan, B.P., Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur. J. Immunol. 33 (2003), 522–531.
193. Kerr, H., Richards, A., Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome. Immunobiology 217 (2012), 195–203.
194. Fujita, T., Evolution of the lectin-complement pathway and its role in innate immunity. Nat. Rev. Immunol. 2 (2002), 346–353.
195. Holmskov, U., Thiel, S., Jensenius, J.C., Collections and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21 (2003), 547–578.
196. Jensenius, H., Klein, D.C., van Hecke, M., Oosterkamp, T.H., Schmidt, T., Jensenius, J.C., Mannan-binding lectin: structure, oligomerization, and flexibility studied by atomic force microscopy. J. Mol. Biol. 391 (2009), 246–259.
197. Heja, D., Kocsis, A., Dobó, I., Szilágyi, K., Szász, R., Závodszky, P., Pál, G., Gál, P., Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP1 as the exclusive activator of MASP-2. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 10498–10503.
198. Hamad, I., Hunter, A.C., Rutt, K.J., Moghimi, S.M., Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover. Mol. Immunol. 45 (2008), 3797–3803.
199. Andersen, A.J., Robinson, J.T., Dai, H., Andresen, T.L., Moghimi, S.M., Single-walled carbon nanotube surface control of complement recognition and activation. ACS Nano 7 (2013), 1108–1119.
200. Banda, N.K., Mehta, G., Chao, Y., Inturi, S., Fossati-Jimak, L., Botto, M., Wu, L., Moghimi, S.M., Simberg, D., Mechanisms of complement activation by dextran-coated superparmagnetic iron oxide (SPIO) nanoworms in mouse versus human serum. Part. Fibre Toxicol., 11, 2014, 64.
201. Inturi, S., Wang, G., Chen, F., Banda, N.K., Holers, V.M., Wu, L., Moghimi, S.M., Simberg, D., Modulatory role of surface coating of superparamagnetic iron oxide nanoworms in complement opsonisation and leukocyte uptake. ACS Nano 9 (2015), 10758–10768.
202. Wang, G., Chen, F., Banda, N.K., Holers, V.M., Wu, L., Moghimi, S.M., Simberg, D., Activation of human complement system by dextran-coated iron oxide nanoparticles is not affected by dextran/Fe ratio, hydroxyl modifications, and crosslinking. Front. Immunol., 7, 2016, 418.
203. Hamad, I., Hunter, A.C., Moghimi, S.M., Complement monitoring of Pluronic 127 gel and micelles: suppression of copolymer-mediated complement activation by elevated serum levels of HDL, LDL, and apolipoproteins A1 and B-100. J. Controlled Release 170 (2013), 167–174.
204. Matsushita, M., Fujita, T., Cleavage of the third component of complement (C3) by mannose-binding-protein-associated serine protease (MASP) with subsequent complement activation. Immunobiology 194 (1995), 443–448.
205. Dobo, J., Szakács, D., Oroszlán, G., Kortvely, E., Kiss, B., Boros, E., Szász, R., Závodszky, P., Gál, P., Pál, G., MASP-3 is the exclusive pro-factor D activator in resting blood: the lectin and the alternative complement pathways are fundamentally linked. Sci. Rep., 6, 2016, 31877.
206. Yu, K., Lai, B.F.L., Foley, J.H., Krisinger, M.J., Conway, E.M., Kizhakkedathu, J.N., Modulation of coplement activation and amplification on nanoparticle surfaces by glycopolymer conformation and chemistry. ACS Nano 8 (2014), 7687–7703.
207. ®, DOXOrubicin, and SinaDoxosome. J. Controlled Release 221 (2016), 1–8.
208. Moghimi, S.M., Hamad, I., Andresen, T.L., Jørgensen, K., Szebeni, J., Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production. FASEB J. 20 (2006), 2591–2593.
209. Klapper, Y., Hamad, O.A., Teramura, Y., Leneweit, G., Nienhaus, G.U., Ricklin, D., Lambris, J.D., Ekdahl, K.N., Nilsson, B., Mediation of a non-proteolytic activation of complement component C3 by phospholipid vesicles. Biomaterials 35 (2014), 3688–3696.
210. Chen, F., Wang, G., Griffin, J.I., Brenneman, B., Banda, N.K., Holers, V.M., Backos, D.S., Wu, L., Moghimi, S.M., Simberg, D., Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo. Nat. Nanotechnol. 12 (2017), 387–393.
211. Moghimi, S.M., Szebeni, J., Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonisation and protein-binding properties. Prog. Lipid Res. 42 (2003), 463–478.
212. Wibroe, P.P., Azmi, I.D.M., Nilsson, C., Yaghmur, A., Moghimi, S.M., Citrem modulates internal nanostructure of glyceryl monooleate dispersions and bypasses complement activation: towards development of safe tunable intravenous lipid nanocarriers. Nanomedicine 11 (2015), 1909–1914.
213. Azmi, I.D.M., Wibroe, P.P., Wu, L.-P., Kazem, A.I., Amenitsch, H., Moghimi, S.M., Yaghmur, A., A structurally diverse library of safe-by-design citrem-phospholipid lamellar and non-lamellar liquid crystalline nano-assemblies. J. Controlled Release 239 (2016), 1–9.
214. Sou, K., Tsuchida, E., Electrostatic interactions and complement activation on the surface of phospholipid vesicle containing acidic lipids: effect of the structure of acidic groups. Biochim. Biophys. Acta-Biomembr. 1778 (2008), 1035–1041.
215. Mizrahy, S., Raz, S.R., Hasgaard, M., Liu, H., Soffer-Tsur, N., Cohen, K., Dvash, R., Landsman-Milo, D., Bremer, M.G.E.G., Moghimi, S.M., Peer, D., Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response. J. Controlled Release 156 (2011), 231–238.
216. Moghimi, S.M., Hunter, A.C., Murray, J.C., Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53 (2001), 283–318.
217. Wu, Y.Q., Qu, H.C., Sfyroera, G., Tzekou, A., Kay, B.R., Nilsson, B., Ekdahl, K.N., Ricklin, D., Lambris, J.D., Protection of nonself surfaces from complement attack by factor H-binding peptides: implications for therapeutic medicine. J. Immunol 186 (2011), 4269–4277.
218. Moghimi, S.M., Simberg, D., Complement activation turnover on surfaces of nanoparticles. Nano Today, 2017, 10.1016/j.nanotod.2017.03.001 in press.
219. Wilhelm, S., Tavares, A.J., Dai, Q., Ohta, S., Audet, J., Dvorak, H.F., Chan, W.C.W., Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater., 1(2016), 2016, 16014.
220. Anselmo, A.C., Modery-Pawlowski, C.L., Menegatti, S., Kumar, S., Vogus, D.R., Tian, L.L., Chen, M., Squires, T.M., Sen Gupta, A., Mitragotri, S., Platelet-like nanoparticles: mimicking shape, flexibility, and surface biology of platelets to target vascular injuries. ACS Nano 8 (2014), 11243–11253.
221. Key, J., Palange, A.L., Gentile, F., Aryal, S., Stigliano, C., Di Mascolo, D., De Rosa, E., Cho, M., Lee, Y., Singh, J., Decuzzi, P., Soft discoidal polymeric nanoconstructs resist macrophage uptake and enhance vascular targeting in tumors. ACS Nano 9 (2015), 11628–11641.
222. Kuhn, D.A., Vanhecke, D., Michen, B., Blank, F., Gehr, P., Petri-Fink, A., Rothen-Rutishauser, B., Different endocytotic uptake mechanisms for nanoparticles in epithelial cells and macrophages. Beilstein J. Nanotechnol. 5 (2014), 1625–1636.
223. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, P., Transport into the cell from the plasma membrane: endocytosis. Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, P., (eds.) Molecular Biology of the Cell, 4th edition, 2002, Garland Science, New York.
224. Boraschi, D., Costantino, L., Italiani, P., Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine (Lond.) 7 (2012), 121–131.
225. Oh, N., Park, J.-H., Endocytosis and exocytosis of nanoparticles in mammalian cells. Int. J. Nanomed. 9 (2014), 51–63.
226. Weissleder, R., Nahrendorf, M., Pittet, M.J., Imaging macrophages with nanoparticles. Nat. Mater. 13 (2014), 125–138.
227. Paul, D., Achouri, S., Yoon, Y.-Z., Herre, J., Bryant, C.E., Cicuta, P., Phagocytosis dynamics depends on target shape. Biophys. J. 105 (2013), 1143–1150.
228. Champion, J.A., Walker, A., Mitragotri, S., Role of particle size in phagocytosis of polymeric microspheres. Pharm. Res. 25 (2008), 1815–1821.
229. Decuzzi, P., Ferrari, M., Design maps for nanoparticles targeting the diseased microvasculature. Biomaterials 29 (2008), 377–384.
230. Decuzzi, P., Ferrari, M., The adhesive strength of non-spherical particles mediated by specific interactions. Biomaterials 27 (2006), 5307–5314.
231. Monopoli, M.P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., Dawson, K.A., Physical- chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. JACS 133 (2011), 2525–2534.
232. Lesniak, A., Fenaroli, F., Monopoli, M.P., Åberg, C., Dawson, K.A., Salvati, A., Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano 6 (2012), 5845–5857.
233. Patra, A., Ding, T., Engudar, G., Wang, Y., Dykas, M.M., Liedberg, B., Kah, J.C.Y., Venkatesan, T., Drum, C.L., Component-specific analysis of plasma protein corona formation on gold nanoparticles using multiplexed surface plasmon resonance. Small 12 (2016), 1174–1182.
234. Sosale, N.G., Spinler, K.R., Alvey, C., Discher, D.E., Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization a species-specific ‘Marker of Self'CD47, and target physical properties. Curr. Opin. Immunol. 35 (2015), 107–112.
235. Qie, Y., Yuan, H., Von Roemeling, C.A., Chen, Y., Liu, X., Shih, K.D., Knight, J.A., Tun, H.W., Wharen, R.E., Jiang, W., Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes. Sci. Rep., 6, 2016, 26269.
236. Moghimi, S.M., Andersen, A.J., Hashemi, S.H., Lettiero, B., Ahmadvand, D., Hunter, A., Andresen, T.L., Hamad, I., Szebeni, J., Complement activation cascade triggered by PEG–PL engineered nanomedicines and carbon nanotubes: the challenges ahead. J. Controlled Release 146 (2010), 175–181.
237. Schöttler, S., Becker, G., Winzen, S., Steinbach, T., Mohr, K., Landfester, K., Mailänder, V., Wurm, F.R., Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers. Nat. Nanotechnol. 11 (2016), 372–377.
238. Champion, J.A., Mitragotri, S., Shape induced inhibition of phagocytosis of polymer particles. Pharm. Res. 26 (2009), 244–249.
239. Doshi, N., Mitragotri, S., Macrophages recognize size and shape of their targets. PLoS One, 5, 2010 e10051.
240. Sharma, G., Valenta, D.T., Altman, Y., Harvey, S., Xie, H., Mitragotri, S., Smith, J.W., Polymer particle shape independently influences binding and internalization by macrophages. J. Controlled Release 147 (2010), 408–412.
241. Banerjee, A., Qi, J., Gogoi, R., Wong, J., Mitragotri, S., Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J. Controlled Release 238 (2016), 176–185.
242. Janát-Amsbury, M., Ray, A., Peterson, C., Ghandehari, H., Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur. J. Pharm. Biopharm. 77 (2011), 417–423.
243. Palomba, R., Parodi, A., Evangelopoulos, M., Acciardo, S., Corbo, C., De Rosa, E., Yazdi, I., Scaria, S., Molinaro, R., Furman, N.T., Biomimetic carriers mimicking leukocyte plasma membrane to increase tumor vasculature permeability. Sci. Rep., 6, 2016.
244. Rodriguez, P.L., Harada, T., Christian, D.A., Pantano, D.A., Tsai, R.K., Discher, D.E., Minimal self peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles. Science 339:2013 (2013), 971–975.
245. Best, J.P., Yan, Y., Caruso, F., The role of particle geometry and mechanics in the biological domain. Adv. Healthcare Mater. 1 (2012), 35–47.
246. Sen Gupta, A., Role of particle size, shape, and stiffness in design of intravascular drug delivery systems: insights from computations experiments, and nature. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 8 (2016), 255–270.
247. Engler, A.J., Sen, S., Sweeney, H.L., Discher, D.E., Matrix elasticity directs stem cell lineage specification. Cell 126 (2006), 677–689.
248. Rehfeldt, F., Engler, A.J., Eckhardt, A., Ahmed, F., Discher, D.E., Cell responses to the mechanochemical microenvironment – implications for regenerative medicine and drug delivery. Adv. Drug Deliv. Rev. 59 (2007), 1329–1339.
249. Kloxin, A.M., Benton, J.A., Anseth, K.S., In situ elasticity modulation with dynamic substrates to direct cell phenotype. Biomaterials 31 (2010), 1–8.
250. Discher, D.E., Mooney, D.J., Zandstra, P.W., Growth factors, matrices, and forces combine and control stem cells. Science 324 (2009), 1673–1677.
251. Discher, D.E., Janmey, P., Wang, Y.-I., Tissue cells feel and respond to the stiffness of their substrate. Science 310 (2005), 1139–1143.
252. Becker, A.L., Johnston, A.P., Caruso, F., Layer-by-layer-assembled capsules and films for therapeutic delivery. Small 6 (2010), 1836–1852.
253. Zhang, L., Feng, Q., Wang, J., Zhang, S., Ding, B., Wei, Y., Dong, M., Ryu, J.-Y., Yoon, T.-Y., Shi, X., Microfluidic synthesis of hybrid nanoparticles with controlled lipid layers: understanding flexibility-regulated cell-nanoparticle interaction. ACS Nano 9 (2015), 9912–9921.
254. Sun, J., Zhang, L., Wang, J., Feng, Q., Liu, D., Yin, Q., Xu, D., Wei, Y., Ding, B., Shi, X., Tunable rigidity of (polymeric core)–(lipid shell) nanoparticles for regulated cellular uptake. Adv. Mater. 27 (2015), 1402–1407.
255. Müllner, M., Dodds, S.J., Nguyen, T.-H., Senyschyn, D., Porter, C.J., Boyd, B.J., Caruso, F., Size and rigidity of cylindrical polymer brushes dictate long circulating properties in vivo. ACS Nano 9 (2015), 1294–1304.
256. Sosale, N.G., Rouhiparkouhi, T., Bradshaw, A.M., Dimova, R., Lipowsky, R., Discher, D.E., Cell rigidity and shape override CD47’s self-signaling in phagocytosis by hyperactivating myosin-II. Blood 125 (2015), 542–552.
257. Anselmo, A.C., Zhang, M., Kumar, S., Vogus, D.R., Menegatti, S., Helgeson, M.E., Mitragotri, S., Elasticity of nanoparticles influences their blood circulation, phagocytosis, endocytosis, and targeting. ACS Nano 9 (2015), 3169–3177.
258. Beningo, K.A., Wang, Y.-I., Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. J. Cell Sci. 115 (2002), 849–856.
259. Banquy, X., Suarez, F., Argaw, A., Rabanel, J.-M., Grutter, P., Bouchard, J.-F., Hildgen, P., Giasson, S., Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake. Soft Matter 5 (2009), 3984–3991.
260. Alexander, J.F., Kozlovskaya, V., Chen, J., Kuncewicz, T., Kharlampieva, E., Godin, B., Cubical shape enhances the interaction of layer-by-layer polymeric particles with breast cancer cells. Adv. Healthcare Mater. 4 (2015), 2657–2666.
261. Palange, A.L., Palomba, R., Rizzuti, I.F., Ferreira, M., Decuzzi, P., Deformable discoidal polymeric nanoconstructs for the precise delivery of therapeutic and imaging agents. Mol. Ther. 25 (2017), 1514–1521.
262. Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., Discher, D.E., Shape effects of filaments versus spherical particles in flow and drug delivery. Nat. Nanotechnol. 2 (2007), 249–255.
263. Merkel, T.J., Jones, S.W., Herlihy, K.P., Kersey, F.R., Shields, A.R., Napier, M., Luft, J.C., Wu, H., Zamboni, W.C., Wang, A.Z., Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 586–591.
264. Anselmo, A.C., Mitragotri, S., Impact of particle elasticity on particle-based drug delivery systems. Adv. Drug Deliv. Rev. 108 (2017), 51–67.
265. Smith, B.R., Ghosn, E.E., Rallapalli, H., Prescher, J.A., Larson, T., Herzenberg, L.A., Gambhir, S.S., Selective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour delivery. Nat. Nanotechnol. 9 (2014), 481–487.
266. Miller, M.A., Zheng, Y.R., Gadde, S., Pfirschke, C., Zope, H., Engblom, C., Kohler, R.H., Iwamoto, Y., Yang, K.S., Askevold, B., Kolishetti, N., Pittet, M., Lippard, S.J., Farokhzad, O.C., Weissleder, R., Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat. Commun., 6, 2015, 8692.
267. Smith, D.M., Simon, J.K., Baker, J.R., Applications of nanotechnology for immunology. Nat. Rev. Immunol. 13 (2013), 592–605.
268. Westmeier, D., Knauer, S.K., Stauber, R.H., Docter, D., Bio-nano interactions. Fadeel, B., Pietroiusti, A., Shvedova, A., (eds.) Adverse Effects of Engineered Nanomaterials: Exposure, Toxicology, and Impact on Human Health, second edition, 2017, Elsevier-Academic Press, Amsterdam, 3–14.
269. Brodin, P., Davis, M.M., Human immune system variation. Nat. Rev. Immunol. 17 (2017), 21–29.
270. Kaczorowski, K.J., Shekhar, K., Nkulikiyimfura, D., Dekker, C.L., Maecker, H., Davis, M.M., Chakraborty, A.K., Brodin, P., Continuous immunotypes describe human immune variation and predict diverse responses. Proc. Natl. Acad. Sci. U. S. A. 14 (2017), E6097–E6106, 10.1073/pnas.1705065114 pii: 201705065 [Epub ahead of print].